EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
© Lescaille et al; licensee BioMed Central Ltd. 2012
Received: 9 August 2011
Accepted: 23 March 2012
Published: 23 March 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|9 Aug 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|6 Oct 2011||Reviewed||Reviewer Report - Stanley Zucker|
|10 Oct 2011||Reviewed||Reviewer Report - Nadarajah Vigneswaran|
|12 Oct 2011||Reviewed||Reviewer Report - Wolfgang Zacharias|
|14 Oct 2011||Reviewed||Reviewer Report - Kazuki Nabeshima|
|28 Dec 2011||Author responded||Author comments - Samia Mourah|
|Resubmission - Version 3|
|28 Dec 2011||Submitted||Manuscript version 3|
|4 Jan 2012||Reviewed||Reviewer Report - Stanley Zucker|
|6 Jan 2012||Reviewed||Reviewer Report - Nadarajah Vigneswaran|
|11 Jan 2012||Reviewed||Reviewer Report - Wolfgang Zacharias|
|23 Jan 2012||Reviewed||Reviewer Report - Kazuki Nabeshima|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|23 Mar 2012||Editorially accepted|
|23 Mar 2012||Article published||10.1186/1471-2407-12-115|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.